Identification of pathogenic macrophage subpopulations in lung disease Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD Year: 2012
Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020
The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017
The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021
Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009
Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021
The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015
TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001
Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020 Year: 2020
Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020 Year: 2020
Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020
Post-viral effects on the susceptibility of developing chronic lung diseases Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018
Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002
Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020 Year: 2020
Neutrophils in CF lung disease Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008
Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis Source: Eur Respir J 2016; 47:1797-1808 Year: 2016
The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018 Year: 2019
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006
Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019